Copyright
©The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved.
Completion of 6-mo isoniazid preventive treatment among eligible under six children: A cross-sectional study, Lagos, Nigeria
Victor Abiola Adepoju, Ademola Adelekan, Aderonke Agbaje, Femi Quaitey, Tobi Ademola-Kay, Ann Uduak Udoekpo, Olusola Daniel Sokoya
Victor Abiola Adepoju, Department of HIV and Infectious Diseases, Jhpiego Nigeria, Federal Capital Territory, Abuja 900918, Nigeria
Ademola Adelekan, Department of Research, Bluegate Research Institute, Ibadan 211271, Oyo State, Nigeria
Aderonke Agbaje, Clinical Services, Institute of Human Virology of Nigeria, Abuja 900918, Nigeria
Femi Quaitey, Department of HIV and Infectious Diseases, Jhpiego Nigeria, Uyo 520108, AkwaIbom, Nigeria
Tobi Ademola-Kay, Adolescent and Youth Care, Youth Development and Empowerment Initiative, Lagos 23401, Nigeria
Ann Uduak Udoekpo, Monitoring and Evaluation, Jhpiego Nigeria, Uyo 520108, AkwaIbom, Nigeria
Olusola Daniel Sokoya, Lagos State Tuberculosis, Buruli Ulcer and Leprosy Control Program, Ikeja 100001, Lagos, Nigeria
Author contributions: Adepoju VA and Adelekan A designed the study; Adepoju VA, Sokoya OD and Adelekan A drafted the manuscript; Agbaje A, Ademola-Kay T, Quaitey F, and Udoekpo A revised it critically for important intellectual content; Agbaje A, Quaitey F, Udoekpo A and Sokoya OD contributed to the analysis and interpretation of data; Adepoju VA is the corresponding author of this manuscript, gave final approval of the manuscript submitted.
Institutional review board statement: The study is a retrospective review and abstraction of data from register with no human subject involvement, hence ethical review was not indicated. Informed consent statement: Informed consent was taken from mothers of children involved in this retrospective study. Permission was also received from the Lagos State TB, Buruli Ulcer and Leprosy Control Program.
Informed consent statement: Verbal consent was taken from the parent/caregiver of the children before placing them on INH.
Conflict-of-interest statement: All the authors report no relevant conflicts of interest for this article.
Data sharing statement: Technical appendix, statistical code, and dataset are available from the corresponding author on request.
STROBE statement: The authors have read the STROBE Statement—checklist of items, and the manuscript was prepared and revised according to the STROBE Statement—checklist of items.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See:
https://creativecommons.org/Licenses/by-nc/4.0/ Corresponding author: Victor Abiola Adepoju, MBChB, MSc, Doctor, Senior Editor, Department of HIV and Infectious Diseases, Jhpiego Nigeria, Federal Capital Territory, Plot 971, Rueben Okoya Crescent, Wuye, Abuja 900918, Nigeria. schrodinga05@yahoo.com
Received: October 6, 2022
Peer-review started: October 6, 2022
First decision: October 27, 2022
Revised: November 15, 2022
Accepted: December 23, 2022
Article in press: December 23, 2022
Published online: January 6, 2023
